Actavis, a specialty pharmaceutical company formerly known as Watson Pharmaceuticals, plans to expand its pharmaceutical manufacturing and warehousing facilities in Davie, Fla., resulting in the creation of 220 jobs.

The expansion will involve the construction of a 30,000 square foot addition comprising approximately 16,700 square feet of pharmaceutical manufacturing space and 13,000 square feet of warehouse space. To increase production, Actavis will invest about $40.5 million at the Davie site, which will include the construction of the additional space, as well as investment within its existing facility. Construction is slated to begin in the third quarter of 2013, with completion anticipated in one year and initiation of operations to follow.

Actavis has been approved for nearly $2.9 million in grants, tax refunds and employee training incentives (state and local) to support its expansion. Organizations that assisted the company in facilitating its expansion were Enterprise Florida, Greater Fort Lauderdale Alliance, State of Florida and the Town of Davie.

The Actavis Davie manufacturing facility, in operation since 1992, comprises manufacturing, warehouse, quality, engineering and shared services. The site manufactures about 2.2 billion units annually and is approved by the FDA, Health Canada, and the EMA.